ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc (TARS)

52.69
-2.55
(-4.62%)
Closed January 10 3:00PM
53.00
0.31
(0.59%)
After Hours: 4:52PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
53.00
Bid
50.22
Ask
57.50
Volume
807,895
51.935 Day's Range 54.38
20.0818 52 Week Range 57.14
Market Cap
Previous Close
55.24
Open
54.05
Last Trade
6
@
53.45
Last Trade Time
Financial Volume
US$ 42,614,796
VWAP
52.7479
Average Volume (3m)
766,955
Shares Outstanding
38,226,929
Dividend Yield
-
PE Ratio
-14.80
Earnings Per Share (EPS)
-3.55
Revenue
17.45M
Net Profit
-135.89M

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex ... Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Dover, Delaware, USA
Founded
-
Tarsus Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TARS. The last closing price for Tarsus Pharmaceuticals was US$55.24. Over the last year, Tarsus Pharmaceuticals shares have traded in a share price range of US$ 20.0818 to US$ 57.14.

Tarsus Pharmaceuticals currently has 38,226,929 shares outstanding. The market capitalization of Tarsus Pharmaceuticals is US$2.11 billion. Tarsus Pharmaceuticals has a price to earnings ratio (PE ratio) of -14.80.

TARS Latest News

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarter Strengthened payer coverage highlighted by securing the two...

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

Humana CMO brings more than two decades of experience driving innovative, value-based initiatives designed to improve patient outcomes IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Tarsus...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.465-4.4442441179155.4655752.6104807255.68291802CS
423.921568627455157.1449.86566767254.39479695CS
1215.7342.205527233737.2757.1435.8476695547.81534443CS
2624.5786.422792824528.4357.1420.081871874037.71200843CS
5232.52158.789062520.4857.1420.081871385334.76687676CS
15630.64137.03041144922.3657.1410.800139264527.63759918CS
26034.7189.61748633918.363.6910.800129363727.89932092CS

TARS - Frequently Asked Questions (FAQ)

What is the current Tarsus Pharmaceuticals share price?
The current share price of Tarsus Pharmaceuticals is US$ 53.00
How many Tarsus Pharmaceuticals shares are in issue?
Tarsus Pharmaceuticals has 38,226,929 shares in issue
What is the market cap of Tarsus Pharmaceuticals?
The market capitalisation of Tarsus Pharmaceuticals is USD 2.11B
What is the 1 year trading range for Tarsus Pharmaceuticals share price?
Tarsus Pharmaceuticals has traded in the range of US$ 20.0818 to US$ 57.14 during the past year
What is the PE ratio of Tarsus Pharmaceuticals?
The price to earnings ratio of Tarsus Pharmaceuticals is -14.8
What is the cash to sales ratio of Tarsus Pharmaceuticals?
The cash to sales ratio of Tarsus Pharmaceuticals is 115.25
What is the reporting currency for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Tarsus Pharmaceuticals?
The latest annual turnover of Tarsus Pharmaceuticals is USD 17.45M
What is the latest annual profit for Tarsus Pharmaceuticals?
The latest annual profit of Tarsus Pharmaceuticals is USD -135.89M
What is the registered address of Tarsus Pharmaceuticals?
The registered address for Tarsus Pharmaceuticals is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the Tarsus Pharmaceuticals website address?
The website address for Tarsus Pharmaceuticals is www.tarsusrx.com
Which industry sector does Tarsus Pharmaceuticals operate in?
Tarsus Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.7M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.69M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.45M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.69M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.83M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.31M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

Your Recent History

Delayed Upgrade Clock